pentobarbital will lessen the level or impact of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not encouraged; strong cytochrome P450 enzyme inducers lessen systemic exposure to roflumilast and will lessen the therapeutic usefulnessAs opposed to learning the tectonic shifts on the overall ec